Dayita Banerjee/ LinkedIn
Jul 26, 2026, 08:51
Dayita Banerjee: Presenting New Insights in Fibrinolysis Research at ISTH 2026
Dayita Banerjee, PHD Student at Michigan State University, shared a post on LinkedIn:
“Such an exciting time attending and presenting at my first International Society on Thrombosis and Haemostasis (ISTH) meeting.
Thank you to those of you who came by my poster, ‘Tissue plasminogen activator drives acetaminophen-induced hepatotoxicity independently of plasminogen.’
It was great to connect with you all in Paris. Looking forward to staying in touch.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:14Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy
-
Sep 20, 2026, 01:04Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
-
Sep 20, 2026, 01:02Mohamed Abo-Aly: Which Antiseizure Medication is Safest for Patients on DOACs?
-
Sep 20, 2026, 00:58Hamza Rafiq: How Does a Deep Vein Thrombosis Become a PE?